AHSG and Marchiafava-Bignami disease: Whether this is due to the additive effect of sevelamer HCl on lipids, inflammation, uric acid and fetuin-A [29], or, alternatively, to a reduction in calcium’s skeletal buffering capacity associated with CKD-MBD [28] cannot be investigated with the current data.